Want to join the conversation?
$PFE 2Q15 Q&A: Gilbert of Deutsche Bank asked about the immune-oncology franchise. Ian replied that the company will be first in some tumor types with the PDL1 from Merck and will be well positioned with multiple combinations of immune-oncology assets and combinations of its own in-line assets to be very effective in those combinations.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.